49
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Changes in pain during a depressive episode and relationship to cytokine levels in major depressive disorder

, , , &
Pages 181-188 | Received 12 Nov 2022, Accepted 24 Nov 2023, Published online: 22 Jan 2024

References

  • Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34(1):119–138. doi:10.1146/annurev-publhealth-031912-114409.
  • Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6(4):301–355.
  • Fishbain DA, Cole B, Lewis JE, et al. Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review. Pain Med. 2014;15(9):1522–1539. doi:10.1111/pme.12448.
  • Romano JM, Turner JA. Chronic pain and depression: does the evidence support a relationship? Psychol Bull. 1985;97(1):18–34. doi:10.1037/0033-2909.97.1.18.
  • Merskey H, Watson GD. The lateralisation of pain. Pain. 1979;7(3):271–280. doi:10.1016/0304-3959(79)90084-8.
  • Von Korff M, Simon G. The relationship between pain and depression. Br J Psychiatry Suppl. 1996;168(30):101–108. doi:10.1192/S0007125000298474.
  • Agüera-Ortiz L, Failde I, Mico JA, et al. Pain as a symptom of depression: prevalence and clinical correlates in patients attending psychiatric clinics. J Affect Disord. 2011;130(1-2):106–112. doi:10.1016/j.jad.2010.10.022.
  • Gerrits MMJG, Vogelzangs N, van Oppen P, et al. Impact of pain on the course of depressive and anxiety disorders. Pain. 2012;153(2):429–436. doi:10.1016/j.pain.2011.11.001.
  • Bair MJ, Robinson RL, Eckert GJ, et al. Impact of pain on depression treatment response in primary care. Psychosom Med. 2004;66(1):17–22. doi:10.1097/01.psy.0000106883.94059.c5.
  • Kroenke K, Wu J, Bair MJ, et al. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain. 2011;12(9):964–973. doi:10.1016/j.jpain.2011.03.003.
  • IsHak WW, Wen RY, Naghdechi L, et al. Pain and depression: a systematic review. Harv Rev Psychiatry. 2018;26(6):352–363. doi:10.1097/HRP.0000000000000198.
  • Rosen SF, Ham B, Drouin S, et al. T-Cell mediation of pregnancy analgesia affecting chronic pain in mice. J Neurosci. 2017;37(41):9819–9827. doi:10.1523/JNEUROSCI.2053-17.2017.
  • Anderson CF, Mosser DM. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol. 2002;72(1):101–106. doi:10.1189/jlb.72.1.101.
  • Ribeiro RA, Vale ML, Thomazzi SM, et al. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol. 2000;387(1):111–118. doi:10.1016/s0014-2999(99)00790-6.
  • Liu T, van Rooijen N, Tracey DJ. Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury. Pain. 2000;86(1-2):25–32. doi:10.1016/s0304-3959(99)00306-1.
  • Morris CS, Esiri MM. The expression of cytokines and their receptors in normal and mildly reactive human brain. J Neuroimmunol. 1998;92(1–2):85–97. doi:10.1016/s0165-5728(98)00181-7.
  • Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury. Glia. 2010;58(3):253–263. doi:10.1002/glia.20928.
  • Lee YB, Nagai A, Kim SU. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res. 2002;69(1):94–103. doi:10.1002/jnr.10253.
  • Guo W, Wang H, Watanabe M, et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci. 2007;27(22):6006–6018. doi:10.1523/JNEUROSCI.0176-07.2007.
  • Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi:10.1016/j.biopsych.2009.09.033.
  • Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012;139(3):230–239. doi:10.1016/j.jad.2011.08.003.
  • Dahl J, Ormstad H, Aass HCD, et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology. 2014;45:77–86. doi:10.1016/j.psyneuen.2014.03.019.
  • Gallagher RM, Verma S. Managing pain and comorbid depression: a public health challenge. Semin Clin Neuropsychiatry. 1999;4(3):203–220.
  • Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–2445. doi:10.1001/archinte.163.20.2433.
  • Kroenke K, Bair MJ, Damush TM, et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA. 2009;301(20):2099–2110. doi:10.1001/jama.2009.723.
  • Roughan WH, Campos AI, García-Marín LM, et al. Comorbid chronic pain and depression: shared risk factors and differential antidepressant effectiveness. Front Psychiatry. 2021;12:643609. doi:10.3389/fpsyt.2021.643609.
  • Burke NN, Finn DP, Roche M. Neuroinflammatory mechanisms linking pain and depression. Mod Trends Pharmacopsychiatry. 2015;30:36–50.
  • Campos ACP, Antunes GF, Matsumoto M, et al. Neuroinflammation, pain and depression: an overview of the main findings. Front Psychol. 2020;11:1825. doi:10.3389/fpsyg.2020.01825.
  • Rush AJ, Giles DE, Schlesser MA, et al. The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Res. 1986;18(1):65–87.
  • Rush AJ, Gullion CM, Basco MR, et al. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477–486. doi:10.1017/s0033291700035558.
  • Brambilla F, Maggioni M, Panerai AR, et al. Immune aspects in elderly depression: peripheral blood mononuclear cell responses to mitogen stimulation and cytokine plasma concentrations. Aging. 1997;9(4 Suppl):34–35. doi:10.1007/BF03339696.
  • Pavón L, Sandoval-López G, Eugenia Hernández M, et al. Th2 cytokine response in major depressive disorder patients before treatment. J Neuroimmunol. 2006;172(1–2):156–165. doi:10.1016/j.jneuroim.2005.08.014.
  • Song C, Halbreich U, Han C, et al. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry. 2009;42(5):182–188. doi:10.1055/s-0029-1202263.
  • Helsedirektoratet. Nasjonale retningslinjer for diagnostisering og behandling av voksne med depresjon i primær- og spesialisthelsetjenesten. Helsedirektoratet; 2009.
  • Bai Y-M, Chiou W-F, Su T-P, et al. Pro-inflammatory cytokine associated with somatic and pain symptoms in depression. J Affect Disord. 2014;155:28–34. doi:10.1016/j.jad.2013.10.019.
  • Kroenke K, Shen J, Oxman TE, et al. Impact of pain on the outcomes of depression treatment: results from the RESPECT trial. Pain. 2008;134(1–2):209–215. doi:10.1016/j.pain.2007.09.021.
  • Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011;36(12):2452–2459. doi:10.1038/npp.2011.132.
  • Dionisie V, Filip GA, Manea MC, et al. The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies. Inflammopharmacology. 2021;29(1):75–90. doi:10.1007/s10787-020-00777-5.
  • Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25(4):767–780. doi:10.1016/s0278-5846(01)00155-5.
  • Ho P-S, Yeh Y-W, Huang S-Y, et al. A shift toward T helper 2 responses and an increase in modulators of innate immunity in depressed patients treated with escitalopram. Psychoneuroendocrinology. 2015;53:246–255. doi:10.1016/j.psyneuen.2015.01.008.
  • Dahl J, Ormstad H, Aass HCD, et al. Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels. Acta Psychiatr Scand. 2016;134(1):40–47. doi:10.1111/acps.12576.
  • Ortega A, et al. Psycho-neuro-endocrine-immunological basis of the placebo effect: potential applications beyond pain therapy. Int J Mol Sci. 2022;23(8):4196.
  • Boufidou F, Lambrinoudaki I, Argeitis J, et al. CSF and plasma cytokines at delivery and postpartum mood disturbances. J Affect Disord. 2009;115(1–2):287–292. doi:10.1016/j.jad.2008.07.008.
  • Raison CL, Borisov AS, Majer M, et al. Activation of Central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry. 2009;65(4):296–303. doi:10.1016/j.biopsych.2008.08.010.
  • Dantzer R, Konsman JP, Bluthé RM, et al. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci. 2000;85(1–3):60–65. doi:10.1016/S1566-0702(00)00220-4.
  • Loane DJ, Byrnes KR. Role of microglia in neurotrauma. Neurotherapeutics. 2010;7(4):366–377. doi:10.1016/j.nurt.2010.07.002.
  • Bromander S, Anckarsäter R, Kristiansson M, et al. Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation. 2012;9(1):242. doi:10.1186/1742-2094-9-242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.